Ranbaxy whistleblower petitions PMO to investigate ‘Illegal’ drug approvals

Regulators today lack the “appropriate tools” to penalise pharmaceutical companies for violating the law, he claimed. An email sent to the PMO about the petition remained unanswered till press-time on Sunday.
Source: The Economic Times - Category: Consumer Health News Source Type: news
More News: Health